$6.45—Stale · unknown old
NYSE • Last print unknown ago
$6.45—Stale · unknown old
Direxion Daily S&P Biotech Bear 3X ETF (LABD) is an exchange-traded fund that seeks to deliver three times the inverse of the daily performance of the S&P Biotechnology Select Industry Index. The fund primarily attracts investors looking to hedge against downturns in the biotech sector, which is characterized by high volatility and significant regulatory risks.
LABD generates revenue primarily through management fees based on the assets under management. Its unique position as a leveraged inverse ETF allows it to attract investors seeking to profit from declines in the biotech sector, capitalizing on high volatility and investor sentiment shifts.
Biotech sector performance as measured by the S&P Biotechnology Select Industry Index
Investor sentiment towards biotech stocks, influenced by FDA approvals and clinical trial results
Market volatility and macroeconomic factors affecting risk appetite
Changes in interest rates impacting investor behavior in leveraged products
Regulatory changes affecting the biotech sector could impact the performance of the underlying index.
Technological advancements may disrupt traditional biotech models, impacting investor sentiment.
Emergence of alternative investment vehicles that provide similar exposure without leverage.
Increased competition from other inverse ETFs targeting the biotech sector.
Liquidity risks associated with rapid AUM fluctuations.
Potential for high expense ratios if AUM declines significantly.
moderate - The biotech sector is sensitive to economic cycles, as funding for biotech companies can fluctuate with investor sentiment and economic conditions.
Higher interest rates may reduce demand for leveraged ETFs like LABD, as they can increase the cost of borrowing and reduce risk appetite among investors.
minimal - LABD does not have significant credit exposure as it does not rely on debt financing.
momentum - Investors looking to capitalize on short-term declines in the biotech sector.
high - LABD exhibits high volatility due to its leveraged nature and the inherent volatility of the biotech sector.